Participating in a clinical trial can be lifesaving, and now, more patients than ever have access to life-changing therapies at UAB.

Sickle cell disease is the most common and clinically significant inherited blood disorder across the nation, and now there is an FDA-approved gene therapy to help those living with SCD.

UAB is joining the Red Cross in encouraging the public to donate blood now.

The NIH grant will advance efforts to reduce the gap between research and care of sickle cell disease.

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

UAB’s Julie Kanter, M.D., says statewide surveillance programs for sickle cell disease can help facilitate progress to improve outcomes.

Blood supplies have dropped to critically low levels at UAB.

The collaboration puts UAB experts on the ground in Zambia to strengthen research and public health capacity and address major global health challenges.

Blood supplies have dropped to critically low levels nationwide.

Blood shortages are common in the summer months, and COVID-19 has played havoc with usual donation patterns.

UAB vaccine demographic numbers holding steady as Center Point vaccination site preps for Friday, March 19, opening.

The list was made by a group that aspires to bolster and increase diversity across all scientific fields, promote retention through the “leaky academic pipeline,” and broaden academic and industrial awareness of diversity and inclusion.